Our novel findings demonstrate that the type of dietary protein in HPDs is capable of modulating a variety of obesity-related outcomes, including adipose tissue function, glucose–insulin responses, and pancreatic islet size, independent of overall fat mass and without weight loss. Here, INS is linked to obesity disorder.